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Article focus
  This study aims to identify evidence for 
nonapoptotic bone remodelling mecha-
nisms by osteocytes in microdamaged 
bone.
  Secondly, this study investigates whether 
the Wnt signalling protein sclerostin is 
altered in fractured bone.
Key messages
  This study found that targeted remodel-
ling in the bone is not dependent on 
osteocyte apoptosis.
  The key finding is a marked increase in the 
Wnt signalling inhibitor sclerostin, sug-
gesting that this protein may be produced 
at sites of high bone density in order to 
reduce further bone deposition, therefore 
playing a role in the regulation of bone 
microdamage during stress adaptation.
Strengths and limitations
  This study has a strong clinical sample 
size (n = 30) of distal Mc-III bones, both 
fractured and nonfractured, from 
Thoroughbred horses.
Increased sclerostin associated with 
stress fracture of the third metacarpal 
bone in the Thoroughbred racehorse
Objectives
The exact aetiology and pathogenesis of microdamage-induced long bone fractures remain 
unknown. These fractures are likely to be the result of inadequate bone remodelling in 
response to damage. This study aims to identify an association of osteocyte apoptosis, the 
presence of osteocytic osteolysis, and any alterations in sclerostin expression with a fracture 
of the third metacarpal (Mc-III) bone of Thoroughbred racehorses.
Methods
A total of 30 Mc-III bones were obtained; ten bones were fractured during racing, ten were 
from the contralateral limb, and ten were from control horses. each Mc-III bone was divided 
into a fracture site, condyle, condylar groove, and sagittal ridge. Microcracks and diffuse 
microdamage were quantified. Apoptotic osteocytes were measured using TUneL staining. 
cathepsin K, matrix metalloproteinase-13 (MMp-13), HtrA1, and sclerostin expression were 
analyzed.
Results
In the fracture group, microdamage was elevated 38.9% (sd 2.6) compared with controls. 
There was no difference in the osteocyte number and the percentage of apoptotic cells 
between contralateral limb and unraced control; however, there were significantly fewer 
apoptotic cells in fractured samples (p < 0.02). Immunohistochemistry showed that in deep 
zones of the fractured samples, sclerostin expression was significantly higher (p < 0.03) than 
the total number of osteocytes. no increase in cathepsin K, MMp-13, or HtrA1 was present.
Conclusion
There is increased microdamage in Mc-III bones that have fractured during racing. In this 
study, this is not associated with osteocyte apoptosis or osteocytic osteolysis. The finding of 
increased sclerostin in the region of the fracture suggests that this protein may be playing a 
key role in the regulation of bone microdamage during stress adaptation.
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  This study indicates that microdamage in the race-
horse has a fundamentally different pathological pro-
cess to that modelled in small rodent animals, and 
these results should be further validated in a human 
fracture model.
introduction
long bone fractures in horses have significant welfare 
and economic implications for the horseracing industry. 
a clear understanding of their aetiology and pathogene-
sis is key for the prevention of fractures. In horses, long 
bone fractures occur because of either a one-off overload 
incident or repetitive microdamage and subsequent 
weakening, usually associated with high-intensity exer-
cise. Fractures resulting from microdamage are com-
monly termed ‘stress fractures’ and often present as 
catastrophic fractures when the horse is exercising.1 In 
the united Kingdom, it has been shown that lameness 
was the most important cause of days lost from training 
in two- or three-year-old Thoroughbred horses, and that 
stress fractures are the most significant cause of this lame-
ness, with an incidence of 1.48/100 and 1.43/100 per 
horse month in two- and three-year-old horses, respec-
tively.2,3 a number of bones are affected by stress frac-
tures, including the carpal bones, proximal sesamoid 
bones, tibia, and humerus, with the distal condyle of the 
third metacarpal bone (Mc-III) being one of the most 
common sites to be affected.4,5
a Thoroughbred racehorse runs at speeds exceeding 
15 m/s, applying highly repetitive surface strains of 
> 5000 µε to the Mc-III,6 which in turn leads to microdam-
age accumulating in the joint surface and adjacent sub-
chondral bone plate.7,8 The histological damage can be 
seen in two distinct forms: linear microcracks and diffuse 
microdamage.9-11 During these high-intensity exercise 
regimes, repair of the microdamage is undertaken by 
bone remodelling, which requires the coupling of bone 
resorption and formation, in order to maintain mineral 
homeostasis, adapt to mechanical change, and repair 
damage. The latter two scenarios are site-specific and are 
termed ‘targeted bone remodelling’.12
a stress fracture is likely to be the result of inadequate 
targeted bone remodelling responding to microdamage. 
It occurs when bone resorption exceeds bone formation, 
resulting in weakened bones and the propagation of frac-
ture lines. Targeted bone remodelling is controlled by 
osteocytes, the key roles of which in bone homeostasis 
include regulation of bone formation, control of bone 
resorption (via both apoptotic and nonapoptotic path-
ways), receptor activator of nuclear factor kappa-B ligand 
(raNKl)-mediated signals, and the transduction of 
mechanical signals to induce an appropriate biological 
response.13,14 The regulation of bone formation by osteo-
cytes is predominately via sclerostin production, a Wnt 
signalling inhibitor that inhibits bone formation,15 which 
is in turn modulated by local load.16 Inhibition of 
sclerostin with neutralizing antibodies has been shown to 
accelerate fracture healing17 and sclerostin knockout 
mice have been demonstrated to have faster healing fac-
tures,18 suggesting sclerostin may inhibit bone healing in 
vivo. Nonapoptotic mechanisms of bone remodelling 
include direct remodelling of the perilacunar bone (‘osteo-
cytic osteolysis’).13 osteocytic osteolysis takes place via 
the production by osteocytes of degradative enzymes 
such as cathepsin K,19 metalloproteinase-13 (MMp-13),20 
and the serine protease Htra1,21 as well as the classic 
osteoclast enzyme, tartrate-resistant acid phosphatase 
(Trap). These enzymes can be used as surrogate markers 
for this process. However, while some studies on the 
Thoroughbred racehorse have investigated the role of 
osteocyte apoptosis in stress fractures, no studies have 
been performed in horses to investigate Wnt signalling 
pathways or direct remodelling in microdamaged bone.
This report identifies evidence for nonapoptotic bone 
remodelling mechanisms by osteocytes in microdam-
aged bone, and investigates whether the Wnt signalling 
protein sclerostin is altered in microdamaged bone.
Materials and Methods
Animals. Mc-III bones were obtained from Thoroughbred 
racehorses that had been euthanized on racetracks 
in California (in one of Stockton, arcadia, Berkeley, 
Inglewood, or pomona), united States following a 
catastrophic fracture, and were collected as part of the 
California Horse racing Board post-mortem programme 
(Fig. 1). The study groups were: group F, distal Mc-III 
lateral condylar fractures that occurred on the racetrack 
immediately prior to euthanasia (n = 10), six of which 
were left-leg fractures and four of which were right-leg 
fractures; and the contralateral (Cl) group, distal Mc-III 
contralateral (uninjured) legs from horses in group F 
(n = 10). all horses raced on anticlockwise racecourses, 
so the increased stress was on the left leg. Horses with 
bilateral fractures were excluded, as were those with 
concurrent fracture pathology, such as pre-existing 
stress fractures. a control group, group C, consisting of 
distal Mc-III, comprised Thoroughbred horses who had 
sustained fatal, non-orthopaedic injuries on the race-
track (n = 10). For groups F and Cl, the mean age was 
4.1 years (sd 1.2); for group C, the mean age was 3.9 
years (sd 1.5). For all samples, distal thoracic limbs were 
transected at the level of the carpal bone and stored at 
-20°C after euthanasia. The time to euthanasia was ten 
minutes, and samples were preserved frozen for up to 
six hours post-mortem.
Specimen preparation. a frontal plane bone block of the 
distal Mc-III,22,23 approximately 1 cm thick, was prepared 
using a band saw. The bone block of the joint surface was 
then divided into four pieces using sagittal plane cuts to 
create separate blocks of each of the regions of interest: 
lateral condylar fracture site, medial condyle, medial con-
dylar groove, and sagittal ridge (Fig. 2).23
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Preparation of tissue sections. For each site, both frozen 
and polymethyl methacrylate (pMMa) sections were 
obtained. Frozen samples were subsequently used for 
immunohistochemistry, and pMMa samples were used 
for histological staining. Frozen sections were produced 
by embedding optimal cutting temperature (oCT) Cryo 
embedding compound (SDlaMB/oCT, Fisher Healthcare, 
Norwich, united Kingdom) and snap- freezing in liquid 
nitrogen. Sections of 10 μm thickness were produced 
through the central portion of the bone block using a 
cryostat. The unfixed and non-demineralized tissue cryo-
sections were tape-transferred and glued to slides with 
ultraviolet-sensitive glass adhesive.
To visualize the microdamage within the bones, the 
whole bone was stained prior to sectioning, in order to 
ensure that damage produced during the processing 
would not be stained and would therefore be excluded 
from damage quantification.23,24 This was performed by 
the pMMa sections of the bone block being fixed in 70% 
ethanol and bulk-stained in 1% basic fuchsin (JT Baker 
Basic Fuchsin, JTB-B660-03; Surechem products ltd, 
Ipswich, united Kingdom) in a graded series of ethanols 
(80%, 90%, 100%) for a total staining time of 18 days, 
allowing thorough penetration of staining and de hydration 
of the bones. after embedding in pMMa, 20 µm calcified 
oblique frontal plane sections were prepared from the 
 Fig. 1c Fig. 1d 
Dorsopalmar (anterior/posterior) radiographs of a) intact third metacarpal bone (Mc-III) and b) fractured bone of same horse. photograph of articular surfaces 
of c) intact bone and d) fractured Mc-III. left medial and right lateral side.
 Fig. 2a Fig. 2b Fig. 2c 
Dorsopalmar radiographs of a) fractured third metacarpal bone and b) control and contralateral bone. The different regions used in the analysis of staining are 
shown. a, medial condyle; B, medial condylar groove; C, sagittal ridge; D, lateral condylar fracture site. In c), the sampling site regions are shown, correspond-
ing to a to D in a) and b).
Fig. 1a Fig. 1b
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centre of each block. This basic acid fuchsin technique 
stains microcracks and diffuses matrix damage that 
existed before histological sectioning.25
Visualization of microdamage. The sections of pMMa 
were dehydrated, mounted in DpX mounting medium 
(44581; Sigma-aldrich Co. ltd, london, united Kingdom), 
and dried. Sections were imaged using a fluorescence 
microscope (leica DMrB, leica, Wetzlar, germany), 
and over 200 microscope images per section were 
stitched together using Surveyor image analysis software 
(objective Imaging ltd, Cambridge, united Kingdom) 
and subsequently analyzed with ImageJ software.26 The 
number of microcracks was quantified by expressing the 
number of cracks per section, normalized to the total 
length of the cartilage/subchondral bone interface for 
each section. Branched cracks were counted as one crack 
and each section was scored blind by the same observer 
to ensure consistency between data collection. Diffuse 
damage was quantified by expressing the number of dis-
crete areas of diffuse damage section normalized to the 
total length of the cartilage/subchondral bone interface 
for each section.
Quantification of osteocyte apoptosis. The prevalence 
and location of apoptotic osteocytes/osteoblasts were 
detected using the DeadEnd fluorometric terminal deoxy-
nucleotidyl transferase (TdT) duTp nick end labelling 
(TuNEl) System (g3250; promega, Madison, Wisconsin).
The cryosections were fixed by immersing slides in 
freshly prepared 4% methanol-free formaldehyde solu-
tion in phosphate Buffered Saline (pBS) (pH 7.4) for five 
minutes at room temperature. The slides were then 
washed by immersing in pBS for five minutes and then 
incubated in proteinase K solution (20 μg/ml) to make 
the tissue sections permeable. The sections were then 
incubated with nucleotide mix and recombinant termi-
nal deoxynucleotidyl transferase (rTdT) enzyme at 37°C 
for 60 minutes and the controls sections, without the 
rTdT enzyme, were incubated at the same temperature 
for the same period. The sections were then mounted in 
vECTaSHIElD + 4',6-diamidino-2-phenylindole (DapI) 
(vector lab Cat. H-1200, vector laboratories, Maravai 
lifeSciences, peterborough, united Kingdom) to stain 
nuclei and were immediately analyzed under a fluores-
cence microscope, Nikon Ti-E perfect Focus System 
(Nikon uK limited, Surrey, united Kingdom), using a 
standard fluorescein filter set to view the green fluores-
cence of fluorescein at 520 nm (sd 20) and blue DapI at 
460 nm under a 10× objective. all the nuclei of osteo-
cytes (both live DapI at 460 nm and dead green fluores-
cein at 520 nm) were counted with ImageJ software 
using particle analysis in the nucleus counter plugin. 
all the dead cells were quantified, counting only green 
fluorescein nuclei with ImageJ software, using particle 
analysis in the nucleus counter plugin. From each site, 
a representative area of 0.1 mm2 (about 380 × 280 μm) 
was analyzed from the surface of four different anatomical 
regions (condyle, condylar groove, sagittal ridge, and 
fracture site).
immunohistochemistry. Frozen sections were labelled 
with rb pab sclerostin (ab63097; abcam, Cambridge, 
united Kingdom), rb pab Htra1 (ab38611; abcam), Ms 
maB cathepsin K (ab66267; abcam), and Ms mab MMp-
13 (ab3208; abcam), using anti-Mouse Igg (071M6210; 
Sigma) and anti-rabbit Igg (B8895; Sigma) secondary 
antibodies. a horseradish peroxidase detection method 
was used to detect staining and sections were then 
counterstained with toluidine blue or methyl green to 
allow visual identification of the cells. Sections were 
examined using bright field optics on a leica DMrXa2 
(leica) with a QImaging retiga EX fast 1394 camera sys-
tem (QImaging, Surrey, British Columbia, Canada) under 
a 60× and 100× objective. at each of the anatomical 
sites, the total number of osteocytes and the positively 
labelled osteocytes were quantified in an area of 1 mm2 
in the subchondral bone (immediately beneath the car-
tilage/bone interface (‘surface zone’)) and in an area of 
1 mm2 immediately below this (‘deep zone’) 5 mm to 
10 mm below the surface zone.
Statistical analysis. all samples were processed to collect 
four technical replicates for each experiment and the data 
are presented as mean and standard deviation (sd) with 
the significance level set at p < 0.05. The data were evalu-
ated using Student’s t-test, analysis of variance (aNova), 
and nonparametric Mann-Whitney u test to determine 
statistically significant differences with graphpad prism 
5 software (graphpad Software Inc., la Jolla, California).
Results
Microdamage quantification. This study identified both 
microcracks and diffuse damage in the samples studied 
(Fig. 3). There was significantly increased microcrack 
damage/area in the lateral condylar fracture site of group 
F (7.04 cracks/mm2 (sd 2.91)), compared with group Cl 
(3.18 cracks/mm2 (sd 4.26)) and group C (2.93 cracks/
mm2 (sd 3.85)), p = 0.002 and p = 0.005, respectively. 
The p-value for group F was not significant. When the 
total microcrack damage was compared against the 
other three sites, there was no significant difference. Nor 
was there any significant difference between and of the 
groups at any site in the amount of diffuse damage/area, 
with group F having 3.43 (sd 1.5) discrete areas of stain-
ing, compared with 2.92 (sd 1.45) in group Cl and 2.55 
(sd 1.67) in group C.
Quantification of apoptosis. The DeadEnd fluorometric 
apoptosis analysis detected apoptotic cells in all sam-
ples studied (Fig. 4). When data from all four sites were 
pooled, there were significantly fewer apoptotic osteo-
cytes in group F compared with group Cl (p = 0.002), 
but there was no difference detected in the percentage of 
apoptotic osteocytes when groups F and Cl were com-
pared with group C. The difference was greatest on the 
sagittal ridge where the rate of apoptotic cells was 22.2% 
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(sd 11.0) in group F compared with 47.0% (sd 19.6) in 
group Cl (p = 0.007).
enzyme immunohistochemistry. Matrix metalloprotein-
ase-13 (MMp-13), Htra1, and cathepsin K immunore-
activity were detected in all samples studied. positive 
staining was detected in the cytoplasm of the osteocytes 
in the bone. MMp-13, Htra1, and cathepsin K immuno-
reactivity was not different among groups or anatomical 
sites (Fig. 5).
Sclerostin immunolocalization. Sclerostin immunoreac-
tivity was detected in all samples studied (Fig. 6). positive 
staining was detected in the cytoplasm of the osteocytes 
in the bone. No staining was detected in the cartilage or 
within the blood vessels. No differences between sites 
were detected, except in the lateral condylar fracture 
site groove. at this site, sclerostin immunohistochemistry 
showed that in the subchondral bone under the articular 
surface (‘surface zone’), staining was in the range of 3.9% 
(sd 2.9) of osteocytes staining positive for sclerostin in all 
samples studied. In the deep zone, however, sclerostin 
immunohistochemistry showed that there was a signifi-
cant increase in positive staining in group F compared 
with group Cl, with a mean of 24.4% (sd 19.4) of osteo-
cytes staining positive for sclerostin (p = 0.03) (Fig. 7). In 
group F samples, there was a 4.5-fold increase (p = 0.03) 
in sclerostin protein-positive cells in the deep zone 
(24.4%) compared with the cartilage and bone interface 
(5.4%). In group Cl samples, there was no change in the 
sclerostin protein between surface and deep zones (2.3% 
and 3.1%, respectively) (Fig. 7).
In group C, there was no change in the sclerostin pro-
tein between surface and deep zones (9.5% and 10.5%, 
respectively). However, in the deep zone there was a 2.3-
fold increase in sclerostin protein-positive cells in group 
F (24.4%) compared with group C (10.5%). additionally, 
in the deep zone there was a 7.9-fold increase (p = 0.03) 
Fig. 3a Fig. 3b Fig. 3c
Fig. 3d
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representative micrographs of acid fuchsin-labelled structures in metacarpal bones: a) linear microcrack extending from articular surface; b) staining around 
blood vessels; and c) diffuse microdamage extending from articular surface. d) graph showing the amount of damage per surface area of section for micro-
cracks and diffuse damage. There was no difference in the amount of diffuse damage quantified in the three groups; however, there was a statistically significant 
difference between the amount of microcrack damage/surface area in the lateral condyle (site D, Figure 2) compared with both contralateral and control bones. 
Scale bar 100 μm. F, fractured bones; Cl, contralateral bones; C, control bones. *p ≤ 0.5; †p ≤ 0.005.
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in sclerostin protein-positive cells in group F (24.4%) 
compared with group C (3.1%) (Fig. 7).
Discussion
In this study, we have shown that osteocyte apoptosis 
does not increase in regions of microdamage in the Mc-III 
of Thoroughbred racehorses that sustain fatal lateral con-
dylar fractures. We have demonstrated increased levels of 
a Wnt signalling inhibitor protein, sclerostin, associated 
with the fracture line in the fractured bones, but there was 
no evidence of osteocytic osteolysis in these samples. our 
results suggest therefore that Wnt signalling pathways 
may be important in the aetiology and pathogenesis of 
microdamage-induced stress fractures in Thoroughbred 
racehorses.
Microdamage has been documented in Thoroughbred 
racehorse fractures as evidence of prefracture pathol-
ogy.27,28 In our study, we have confirmed that the microda-
mage is similar to that previously reported,22,25,27,28 by 
presectioning staining of all the samples with acid fuchsin 
and thus ensuring that the microdamage identified was not 
caused by sample preparation.25 We have identified a mean 
of 7.04 microcracks/mm2 (sd 2.91) joint surface in frac-
tured bones, consistent with the findings of riggs et al.22
It has been proposed that the development of linear 
fracture microcracks through repetitive experimental 
 Fig. 5a Fig. 5b Fig. 5c 
representative photomicrographs of immunohistochemistry in osteocytes in the subchondral bone: a) MMp-13, b) cathepsin K, and c) HTra1. osteocytes 
stained positively are seen as black cells in the fractured samples. In a), the cartilage is stained with toluidine blue; in b), the cartilage is stained with methyl 
green. Scale bar 100 μm.
Fig. 4a Fig. 4b Fig. 4c
Fig. 4d Fig. 4e Fig. 4f
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graphs showing: a) quantification of apoptosis within osteocytes in nonfractured and fractured samples; b) raced and non-raced samples; and c) samples 
from the sagittal ridge. There is a statistically significant difference in the numbers of apoptotic cells (p < 0.05) between fractured and nonfractured samples 
(a) and in the numbers of apoptotic cells on the sagittal ridge, with a significant increase in apoptotic cells in the contralateral limb samples (c). No difference 
was recorded in the numbers of osteocytes in the samples d) and e). f) representative microscope image of a fluorometric TuNEl apoptosis analysis. Blue stain 
shows live cell nuclei, green stain shows apoptotic cells. Scale bar 100 μm. F, fractured bones; Cl, contralateral bones, C, control bones.
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loading is associated with a loss of osteocyte viability in 
the region of the microcrack and in the areas that subse-
quently formed resorption spaces.25,29 This has led to the 
concept that the osteocyte has a role as a mechanorecep-
tor in bone, sensing load and regulating bone adapta-
tion.16 a number of small-animal, in vivo studies have 
demonstrated that, in acute models, seven to ten days 
after fracture, osteocytes regulate bone formation through 
an apoptosis-mediated mechanism.30-32 This mechanism 
is currently considered to underlie the control of targeted 
remodelling of microdamage. However, these acute 
small-animal experiments, primarily conducted in the rat 
ulnar fatigue damage model, evaluated very different 
events compared with the chronic, high-velocity over-
loading of the Mc-III experienced by the Thoroughbred 
racehorse and may determine why, in this study, the natu-
rally occurring microdamage is not associated with osteo-
cyte apoptosis. our observations agree with previous 
Fig. 7a
0
10
20
30
40
50 *
F CL C F CL C
Sc
le
ro
st
in
 p
o
si
ti
ve
 c
el
ls
 (
%
)
Cartilage/bone
interface
5 mm to 10 mm
below surface
* *
Fig. 7b Fig. 7c
–20
0
20
40
F CL C
Sc
le
ro
st
in
 p
o
si
ti
ve
 c
el
ls
 (
%
)
Relative increase from surface
to deep zone
Quantification of sclerostin immunohistochemistry within osteocytes in fractured (F), contralateral (Cl) and control limbs (C). There is a significant increase 
(*p < 0.05) in sclerostin immunoreactivity in the deep zone of the fractured bone. In the photograph, the approximate site of the cartilage/bone interface region 
(white arrow) and the deeper region is indicated (black arrow).
 Fig. 6c Fig. 6d 
representative photomicrographs of sclerostin immunohistochemistry: a) subchondral bone area control sample; b) subchondral area fracture sample; c) deep 
zone control sample; and d) deep zone fracture sample. osteocytes – arrowheads in a) and c) – stained positively for sclerostin are seen as black cells in b) and d) 
(group F) and are shown by black arrows. In a), the cartilage is stained with toluidine blue. Scale bar 100 μm. c, cartilage; scb, subchondral bone. The cartilage 
is stained with toluidine blue and is visible in a) and b). The fracture site is to the bottom of the figures in b) and d) (black arrowhead).
Fig. 6a Fig. 6b
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studies in the equine distal Mc-III, where no association 
between targeted remodelling and osteocyte apoptosis 
has been demonstrated.8,33 Taken together, though, these 
studies suggest that targeted bone remodelling in the 
racehorse is not dependent on osteocyte apoptosis, but 
that an alternative mechanism of regulation may be 
involved.8,33 Indeed, data for the contralateral limb in our 
study, in which there was high apoptosis but low micro-
damage, strongly supports this view.
In the rat ulnar model of microdamage, it has been 
hypothesized that osteocyte apoptosis stimulates bone 
remodelling initially via osteoclastic resorption.34 However, 
osteocytes can regulate bone remodelling via other mech-
anisms, for example, by osteocytic osteolysis and Wnt sig-
nalling pathways.35 In osteocytic osteolysis, osteocytes 
directly resorb their surrounding environment via a cath-
epsin K- and/or MMp-13-associated mechanism.20,36 We 
did not, however, find an association between cathepsin 
K, MMp-13, or Htra1 immunoreactivity and bone damage, 
which suggests that osteocytic osteolysis through cathep-
sin K, MMp-13, or Htra1 pathways is not linked to micro-
damage in the racehorse.
In contrast, there was evidence for an association 
between the Wnt signalling pathway and microdamage. 
osteocytes regulate bone formation, primarily via their 
production of the Wnt signalling protein sclerostin, 
which inhibits bone formation15 and responds to local 
load.16 We have identified sclerostin protein in osteocytes 
in all the samples we have studied, especially along the 
fractured line, where there was a marked and significant 
increase in sclerostin-positive osteocytes, which was 
unexpected. In rat ulnar models of a stress fracture, scle-
rostin has been reported to be reduced adjacent to the 
fracture line,37 although these were acute experiments. 
The finding that osteocyte apoptosis is not associated 
with equine microdamage, but is associated with rat 
ulnar microdamage, suggests that microdamage in the 
racehorse has a fundamentally different pathological pro-
cess to that of small animals.
The presence of increased sclerostin associated with a 
fracture line in equine stress fractures is of real interest. 
one explanation could be that the increase in sclerostin is 
a direct result of increased bone density at the site of the 
microdamage and that sclerostin, an inhibitor of bone for-
mation, is being produced locally to prevent further phys-
iological bone mass increases, which cause increased 
stiffness and the likelihood of a fracture. racehorse train-
ing does cause increased bone density in the distal 
Mc-III,38,39 and this bone density has been shown to be 
heterogeneous across the distal Mc-III.39-41 It has been 
suggested that these bone density gradients within the 
bone further drive the formation of microdamage.40 The 
observation that sclerostin is increased at the site of the 
fracture could suggest that sclerostin is being upregu-
lated in order to inhibit excessive bone formation and thus 
prevent decreasing bone density gradients, which in turn 
may ultimately lead to a fracture. However, the fact that 
the increased sclerostin was only seen in the fractured 
bones rather than in the contralateral limb, which had 
experienced similar racing and training conditions, indi-
cates that the increased sclerostin could be an end-stage 
event associated with a high probability of fracture. 
Sclerostin is upregulated by unloading of bone (‘stress 
shielding’),42,43 and it may be that local unloading caused 
by heterogeneous bone density changes is acting as the 
mechanism to drive this increased sclerostin expression. 
The possibility that sclerostin might play a role in reducing 
the physiological consequences of ‘excessive’ bone mass 
has also been suggested by the finding that constitutive 
activation of osteocyte β-catenin in mice increased bone 
mass but also led to significantly increased serum scle-
rostin levels, which may be a protective mechanism.37
There are several limitations with our study. one is 
that the samples studied did not accurately determine 
when the observed increase in sclerostin occurred rela-
tive to the fracture. The observed increase in sclerostin 
could have been produced prior to fracture, between 
fracture and death, or post-mortem. Sclerostin could be 
upregulated post-mortem, although the analysis of the 
other enzymes with the same samples in our study 
showed no change in the protein levels. on the other 
hand, mrNa transcription levels are known to alter within 
minutes after euthanasia.44 However, reduced oxygen 
tension in the body is one of the main changes post- 
mortem, and hypoxic conditioning has been reported to 
reduce sclerostin expression, both on a transcript and 
protein level in osteoblasts, suggesting that sclerostin 
upregulation post-mortem is therefore unlikely.45
The horses included in this study were euthanized within 
ten minutes of the fracture occurring, which compares 
favourably with the longer time between naturally occur-
ring fracture and bone sample acquisition in human stud-
ies. It has been shown that sclerostin levels in a human 
fracture haematoma are significantly increased compared 
with serum levels, indicating that sclerostin is indeed 
induced by a fracture.46 Hence, future studies need to 
ensure rapid collection and fixation of samples prior to pro-
cessing. another limitation of this study is that sclerostin 
was only investigated in the distal metacarpus. Further work 
is therefore required to investigate fractures at other ana-
tomical sites and to analyze any relationship between the 
levels of training and racing and the levels of sclerostin.
In conclusion, this study has shown no evidence of 
any role being played by osteocyte apoptosis or osteo-
cytic osteolysis in the stress fractures of Mc-III in the 
Thoroughbred racehorse. However, a marked increase in 
the Wnt signalling inhibitor sclerostin was detected, sug-
gesting that this protein may be produced to reduce fur-
ther bone deposition as an end-stage event, in a bone 
that has been remodelled too far to sustain its integrity.
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